Li, C.J., Liu, X.J., Bai, L., Yu, Q., Zhang, Q.M., Yu, P. and Yu, D.M. (2014) Efficacy and Safety of Vildagliptin, Saxagliptin or Sitagliptin as Add-On Therapy in Chinese Patients with Type 2 Diabetes Inadequately Controlled with Dual Combination of Traditional Oral Hypoglycemic Agents. Diabetology & Metabolic Syndrome, 6, 1-9.
http://dx.doi.org/10.1186/1758-5996-6-69

has been cited by the following article:

• TITLE: Development and Validation of a High Performance Thin Layer Chromatographic Method for Quantitative Analysis of Saxagliptin

  AUTHORS: Salvala Srividya, Ettireddy Swetha, Ciddi Veeresham

  KEYWORDS: HPTLC, Saxagliptin, Quantitative Analysis, Stress Induced Degradation, Validation, API

  JOURNAL NAME: American Journal of Analytical Chemistry, Vol.6 No.10, September 16, 2015

  ABSTRACT: A simple, specific, accurate and precise high performance thin layer chromatographic method (HPTLC) was developed for the quantitative analysis of Saxagliptin in active pharmaceutical ingredients (APIs) and pharmaceutical dosage forms. The method was achieved using silica gel aluminum plate 60 F254 (10 × 10 cm) as stationary phase and Methanol:Chloroform (6:4 v/v) as mobile phase. The developed plate was scanned densitometrically using UV 222 nm wavelength. The Rf value of Saxagliptin was found to be 0.50 ± 0.02. The developed method was validated according to ICH guidelines. Limit of detection (LOD) and limit of quantification (LOQ) of Saxagliptin by this method were found as 7.96 ng/spot and 26.54 ng/spot, respectively. The method was found to be sensitive, specific, linear, accurate, precise and robust for the quantitative analysis of Saxagliptin in both APIs and marketed tablet formulation.